Regenxbio
RGNX • NASDAQ
Regenxbio is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Curran Simpson, with a market cap of $470.2M.
Market Cap$470.2M
Employees344.0
CEOCurran Simpson
CountryUnited States of America
Healthcare
Biotechnology
Next EarningsMay 11, 2026 · In 2 weeksBefore Market Open · Q1 2026
Financials
Regenxbio FAQ
Common questions about Regenxbio
Regenxbio is scheduled to report earnings for Q1 2026 on May 11, 2026 before market open. Analysts estimate revenue of $25.8M.
Regenxbio has approximately 344 employees.